Issues Related to Sentinel Lymph Node Assessment in the Management of Breast Cancer—What Are Relevant in Pathology Reports?
2011

Sentinel Lymph Node Assessment in Breast Cancer

Sample size: 1000 publication 10 minutes Evidence: moderate

Author Information

Author(s): Patricia Tai, Joseph Kurian, Edward Yu

Primary Institution: Allan Blair Cancer Center

Hypothesis

Is axillary dissection always necessary when the sentinel node is positive?

Conclusion

Patients with micrometastases or isolated tumor cells benefit from adjuvant systemic treatment.

Supporting Evidence

  • Many women previously classified as node-negative are now reclassified as having micrometastatic nodal involvement.
  • Patients with micrometastases or ITC benefit from adjuvant systemic treatment.
  • Completion ALND is not necessary when the estimated risk of non-sentinel node involvement is low.

Takeaway

Doctors are trying to figure out if they need to do more surgery when they find tiny bits of cancer in the first lymph node they check.

Methodology

A search of PubMed and relevant articles from ASTRO and ASCO was performed.

Potential Biases

Heterogeneity in the approach to sentinel node evaluation exists.

Limitations

Some studies had small sample sizes and short follow-up periods.

Participant Demographics

Mean age was 57.6 years; mean tumor size was 1.85 cm.

Statistical Information

P-Value

P < .0001

Confidence Interval

95% CI, 1.01 to 2.47

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.4061/2011/504940

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication